News

Published on 4 Jan 2022 on Zacks via Yahoo Finance

Here's Why You Should Hold on to NextGen (NXGN) Stock Now


Article preview image

NextGen Healthcare, Inc. NXGN is well-poised for growth backed by strong demand for its solutions and strength in electronic health records (EHR). However, stiff competition remains a concern.Shares of this Zacks Rank #3 (Hold) company have lost 1.8% compared with the industry’s decline of 38.2% in a year’s time. The S&P 500 Index has rallied 29.7% in the same time frame.NextGen — with a market capitalization of $1.22 billion — is a developer and marketer of healthcare information systems. It anticipates earnings to improve 8.5% over the next five years. The company has a trailing four-quarter earnings surprise of 16%, on average.

Key Catalysts

NextGen continues to benefit from strong demand for its solutions.In November, Eye Center South started utilizing NextGen Mobile to improve practice efficiency and bolster patient volume and access. In October, Community Health Center of Snohomish County (CHC of Snohomish County), a federally qualified health center (FQHC) in Washington state, adopted the company’s full solution suite including NextGen Enterprise EHR and NextGen Enterprise PM as well as NextGen Population Health and NextGen Patient Experience Platform.In the same month, NextGen’s client Mednax, Inc. expanded its use of NextGen’s integrated platform. Mednax has adopted NextGen Virtual Visits to see and treat patients remotely and NextGen Mobile, which allows its providers to access schedules and records, streamline clinical documentation and collaborate with other care team members all from a smartphone.

NASDAQ.NXGN price evolution
NYSE.MD price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

For new and old investors, taking full advantage of the stock market and investing with confidenc...

Zacks via Yahoo Finance 31 Mar 2023

Mednax (MD) Q2 Earnings Match Estimates

Mednax (MD) came out with quarterly earnings of $0.47 per share, in line with the Zacks Consensus...

Zacks via Yahoo Finance 4 Aug 2022

Mednax (MD) Reports Next Week: Wall Street Expects Earnings Growth

Wall Street expects a year-over-year increase in earnings on higher revenues when Mednax (MD) rep...

Zacks via Yahoo Finance 16 Jul 2022

Zacks.com featured highlights include Boot Barn, Canada Goose, Pediatrix Medical Group, Leap...

For Immediate Release Chicago, IL – July 11, 2022 – Stocks in this week’s article are Boot Barn B...

Zacks via Yahoo Finance 11 Jul 2022

Will Mednax's (MD) New Name Pediatrix Medical be Beneficial?

Mednax, Inc. MD announced changing its corporate name to Pediatrix Medical Group, Inc. The move i...

Zacks via Yahoo Finance 23 Jun 2022

7 Cheap Stocks Under $20 That Could Double Soon

Good things sometimes come in small packages. These seven cheap stocks under $20 all have the pot...

InvestorPlace via Yahoo Finance 7 Jun 2022

Does The Market Have A Low Tolerance For MEDNAX, Inc.'s (NYSE:MD) Mixed Fundamentals?

It is hard to get excited after looking at MEDNAX's (NYSE:MD) recent performance, when its stock ...

Simply Wall St. via Yahoo Finance 4 May 2022

74 Biggest Movers From Yesterday

Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Sta...

Benzinga 29 Apr 2022

Mednax (MD) Q1 Earnings and Revenues Surpass Estimates

Mednax (MD) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Esti...

Zacks via Yahoo Finance 28 Apr 2022

48 Stocks Moving In Thursday's Mid-Day Session

T Stamp Inc. (NASDAQ: IDAI) shares jumped 201% to $6.33. Statera Biopharma, Inc. (NASDAQ: STAB) j...

Benzinga 28 Apr 2022